| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RMD | ResMed Common Stock | Sale | $325,035 | -1,500 | -1.6% | $216.69 | 94,172 | 03 Mar 2023 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The transaction was conducted under a Rule 10b5-1 plan adopted November 29, 2022. |